| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |